Skip to content

The effect of intraoperative esketamine infusion on reducing perioperative opioid consumption in laparoscopic gastrointestinal surgery

The effect of intraoperative esketamine infusion on reducing perioperative opioid consumption in laparoscopic gastrointestinal surgery:A randomized controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066857
Enrollment
Unknown
Registered
2022-12-20
Start date
2022-12-20
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal tumor

Interventions

Esketamine group:Esketamine 0.5mg/kg for anesthesia induction and 0.25mg/kg·h for anesthesia maintenance

Sponsors

Fujian Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1)American Society of Anesthesiologists (ASA) 1 to 3; 2)Age 18–70 years; 3) Scheduled for laparoscopic gastrointestinal surgery

Exclusion criteria

Exclusion criteria: 1) patient refusal to participate 2) allergic or contraindication to study drugs; 3) postoperative transfer to intensive care unit; 4) mental illness or chronic pain that may confuse the effectiveness of pain relief; 5) serious cardiovascular and cerebrovascular diseases or liver and kidney insufficiency; 6) severe anemia (Hb less than 80g/L); 7) BMI greater than 30 or less than 18; 8) any medical or non-medical condition that the investigator deems inappropriate to participate in.

Design outcomes

Primary

MeasureTime frame
Perioperative sufentanil consumption;

Secondary

MeasureTime frame
Pain intensity;First patient-controlled analgesia time;The amount of additional analgesic medication after surgery;Time to first flatus;The additional amount of postoperative antiemetics;Intraoperative vital signs;Intraoperative consumption of propofol;Intraoperative consumption of norepinephrine;

Countries

China

Contacts

Public ContactZenggui Yu

Fujian Provincial Hospital

2271910206@qq.com+86 13509379453

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026